Tema Heart & Health ETF (NASDAQ:HRTS) Sees Large Growth in Short Interest

Tema Heart & Health ETF (NASDAQ:HRTS) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 5,158 shares, an increase of 105.7% from the August 15th total of 2,508 shares. Based on an average daily volume of 2,948 shares, the short-interest ratio is presently 1.7 days. Currently, 0.3% of the shares of the stock are sold short.

Hedge Funds Weigh In On Tema Heart & Health ETF

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Kestra Advisory Services LLC purchased a new stake in shares of Tema Heart & Health ETF during the fourth quarter worth about $27,000. JPMorgan Chase & Co. acquired a new stake in Tema Heart & Health ETF in the 2nd quarter worth about $63,000. XML Financial LLC acquired a new stake in Tema Heart & Health ETF in the 2nd quarter worth about $223,000. Citadel Advisors LLC purchased a new stake in Tema Heart & Health ETF during the 3rd quarter worth approximately $243,000. Finally, Anson Capital Inc. purchased a new stake in Tema Heart & Health ETF during the 2nd quarter worth approximately $297,000.

Tema Heart & Health ETF Stock Up 1.4%

Shares of Tema Heart & Health ETF stock traded up $0.51 on Monday, reaching $36.54. The company’s stock had a trading volume of 207 shares, compared to its average volume of 5,782. Tema Heart & Health ETF has a 52-week low of $29.54 and a 52-week high of $38.87. The company has a market capitalization of $54.44 million, a P/E ratio of 22.06 and a beta of 0.63. The stock has a 50-day moving average price of $37.13 and a 200-day moving average price of $35.24.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.